MENU

News

Latest News Articles

News

10.23.20

FDA Grants Breakthrough Device Status to External Neuromodulator for Essential Tremor
  • KEYWORDS:
  • Movement disorders
  • Neuromodulation
  • Parkinson disease

News

10.21.20

Ghrelin Advances to a Phase 2 Trial for Concussion Treatment
  • KEYWORDS:
  • Brain Concussion
  • Ghrelin
  • Phase 2 clinical trial
  • TBI
TBI

News

10.20.20

FDA Approves Expanded use of Pitolisant for Treatment of Cataplexy in Adults With Narcolepsy
  • KEYWORDS:
  • cataplexy
  • Excessive daytime sleepiness
  • FDA Approvals
  • Narcolepsy
  • Pitolisant
  • Sleep
  • Sleep disorders

News

10.19.20

FDA Extends Expiration Dating for Diazepam Nasal Spray
  • KEYWORDS:
  • Diazepam
  • FDA Approvals
  • Seizures

News

10.16.20

Sodium Phenylbutyrate-Tauroursodiol Extends Survival up to 6 Months in ALS
  • KEYWORDS:
  • ALS
  • Amyotrophic Lateral Sclerosis
  • Taurursodiol-phenylbutyrate

News

10.16.20

Nortriptyline and Duloxetine Better Tolerated in Neuropathic Pain of Cryptogenic Sensory Polyneuropathy
  • KEYWORDS:
  • Cryptogenic Sensory Polyneuropathy
  • Duloxetine
  • mexiletene
  • Neuromuscular disease
  • Neuropathic Pain
  • nortriptyline
  • pregabalin

News

10.16.20

DaxibotulinumtoxinA Provides Clinically Meaningful Improvement of Cervical Dystonia in Phase 3 Trial
  • KEYWORDS:
  • Cervical dystonia
  • DaxibotulinumtoxinA
  • Dystonia
  • Movement disorders
  • Neuromuscular disease

News

10.13.20

FDA Clears Trigeminal Nerve Stimulator Migraine Treatment for Use Without Prescription
  • KEYWORDS:
  • FDA Clearance
  • Migraine
  • Over the Counter
  • Trigeminal Nerve Stimulator

News

10.13.20

New Mixed-Salt Oxybates Effective for Treatment of Hypersomnia in Adults 
  • KEYWORDS:
  • Excessive daytime sleepiness
  • Oxybate
  • Sleep
  • Sleep disorders

News

10.12.20

Dihydroergotamine Results in Pain Relief Within 2 Hours for Acute Migraine
  • KEYWORDS:
  • Dihydroergotamine
  • Headache
  • Migraine
  • Pain

News

10.06.20

Gene Therapy Improves ON Time for Individuals With Parkinson Disease in Phase 3 Trial
  • KEYWORDS:
  • Gene therapy
  • Movement disorders
  • Parkinson disease

News

10.05.20

Clinical Trials of Lorcaserin for Treatment of Dravet Syndrome Continue
  • KEYWORDS:
  • Dravet syndrome
  • Epilepsy
  • Epileptic Syndromes
  • Lorcaserin

News

10.01.20

First Dose of Potential Neuroprotective Agent Administered in Phase 2/3 Trial for Mild-to-Moderate AD
  • KEYWORDS:
  • Alzheimer Disease
  • Early onset Alzheimer disease
  • Phase 2/3 clinical trial

News

10.01.20

Soticlestat in Rare Epilepsies CDKL5 Deficiency and Dup15q Syndrome Phase 2 Clinical Trials
  • KEYWORDS:
  • CDKL5 Deficiency Disorder
  • Epilepsy
  • Phase 2 clinical trial
  • Soticlestat

News

09.30.20

Insomnia May Be Associated With Increased Risk of Cognitive Impairment 
  • KEYWORDS:
  • Cognitive impairment
  • Insomnia
  • Sleep
  • Sleep disorders

News

09.28.20

Risdiplam Improves Motor Function in Infants with Type 1 SMA
  • KEYWORDS:
  • Child neurology
  • Neuromuscular disease
  • Risdiplam
  • Spinal muscular atrophy
Show More
This Month's Issue
Dementia Insights: Primary Prevention of Dementia

Chen Zhao, MD; Jonathan G. Hakun, PhD; Krishnankutty Sathian, MBBS, PhD; and Nikolaos Scarmeas, MD, MS, PhD

Case Challenge: Recurrent Stroke-Like Symptoms

Stephanie Kazi, BS; Caleb Heiberger, BS; and Divyajot Sandhu, MD

Case Report: Neuromyelitis Optica Associated With SARS-CoV-2

Tzu-Ying Chuang, MD, PhD, and Dhanashri Miskin, MD